Skip to content
lifestyle.harcourthealth.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ascelia Pharma
Ascelia Pharma Provides Orviglance(R) Update Following FDA Type a Meeting
October 11, 2026
Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
September 24, 2026
Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA
September 10, 2026
Focus on The Path Forward for Orviglance
August 20, 2026
Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026
August 17, 2026
Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base
July 15, 2026
Ascelia Pharma Provides Orviglance Update
July 12, 2026
Ascelia Pharma Provides Update on the Orviglance NDA
July 3, 2026
Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing
June 30, 2026
Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026
June 9, 2026
1
2
Next Page
→